Oscar Remedies Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 34.62 K
as on 16-11-2024
- Company Age 34 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 Cr
as on 16-11-2024
- Revenue -15.44%
(FY 2023)
- Profit 60.63%
(FY 2023)
- Ebitda 24.88%
(FY 2023)
- Net Worth 54.99%
(FY 2023)
- Total Assets 31.62%
(FY 2023)
About Oscar Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 34.62 K .
The company currently has active open charges totaling ₹2.50 Cr.
Ashwani Lamba, Navdeep Kumar, Asha Dhingra, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230HR1990PTC031079
- Company No.
031079
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationHaryana, Haryana
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Oscar Remedies Pvt Ltd offer?
Oscar Remedies Pvt Ltd offers a wide range of products and services, including Common Disease Medicines, Eye Drops, Anti Infective Drugs & Medicines, Antibacterial Drugs, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, IV Fluids, Injectable Products, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Oscar Remedies?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ashwani Lamba | Director | Current | |
Navdeep Kumar | Director | 16-Oct-1990 | Current |
Asha Dhingra | Director | 01-Jan-1993 | Current |
Ashwani Kumar | Director | 29-Nov-2022 | Current |
Financial Performance of Oscar Remedies.
Oscar Remedies Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.44% decrease. The company also saw a substantial improvement in profitability, with a 60.63% increase in profit. The company's net worth Soared by an impressive increase of 54.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Oscar Remedies?
In 2023, Oscar Remedies had a promoter holding of 58.00% and a public holding of 42.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Oscar Bioscience Private LimitedActive 8 months 4 days
Navdeep Kumar and Asha Dhingra are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 29 Jun 2018 | ₹2.50 Cr | Open |
How Many Employees Work at Oscar Remedies?
Oscar Remedies has a workforce of 46 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oscar Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oscar Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.